Abstract
Background: Human bone marrow stem cell (hBMSC) is a promising candidate in regenerative medicine due to its plasticity and homing ability. However, in vitro survival and therapeutic efficacy of hBMSCs decline with donor age as a result of physiological cellular aging. Objectives: We transfected human telomerase reverse transcriptase (hTERT) into hBMSCs from patients more than 60 years old in the hope of extending cellular life span. Methods: In our study on 11 donors (aged 16-74 years), no telomerase activity was detected in hBMSCs from donors >60 years old. We then performed transient transfection on hBMSC from these elderly donors (n = 4) with hTERT gene using non-viral methods. Results: Transfection efficiency of 38.5% and 55.6% was achieved by lipofection and electroporation with viability at 83% and 44%, respectively. Telomerase was detected on day 5 for all post-transfected samples. Maximum passage number achieved after transfection was >13 (?45 doublings) compared with 6 (?15 doublings) before transfection. Conclusion: We conclude that transient expression of hTERT increased cellular life span of hBMSCs from elderly patients, while maintaining a normal cell morphology and growth rate. Keywords: Cellular life span, human bone marrow stem cell, telomerase, transfection
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
